- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05075447
Treatment Plan for ADHD With Indifferent Traits
October 9, 2021 updated by: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Diagnosis and Treatment Plan for Destructive and Conduct Disorder Children With Indifferent Traits and Emotion Regulation
For children with ADHD aged 4-10 at the time of enrollment, starting from preschool, focusing on apathy and emotional control, using psycho-behavioral measurements, EEG experiments, and eye tracking technology to evaluate and implement targeted Sexual intervention and six-month follow-up.
Establish a diagnosis and treatment decision analysis model and psychological treatment plan for ODD/CD.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Destructive, conduct disorder children have emotional processing defects, including apathy and ruthless traits, emotional disorders, may be early diagnosis of conduct disorder (Conduct Disorder, CD) or attention deficit hyperactivity disorder (Attention Deficit Hyperactivity Disorders, ADHD) comorbid CD sensitivity Sexual indicators, systemic psychotherapy for these children's indifference characteristics and emotional disorders will improve related symptoms.
This study will start with preschool children with ADHD, design evaluation indicators for emotional traits for children aged 4-10, combined with various psychological evaluations, and use advanced brain electricity combined with eye tracking research technology to provide candidate indicators for evaluation; and On the basis of previous research, establish a treatment plan to improve pathological emotional characteristics and emotional disorders; establish a predictive intervention decision model from preschool to school-age ADHD comorbid CD to provide methods for precise diagnosis and treatment options.
The early prevention and intervention of ADHD and CD has practical significance and maneuverability.
Study Type
Interventional
Enrollment (Anticipated)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jingyi Wu, Master
- Phone Number: 008618616014207
- Email: mmmigrant@163.com
Study Contact Backup
- Name: Jingsong Zhang, Ph.D
- Phone Number: +86-021-25076680
- Email: zhangjinsong@xinhuamed.com.cn
Study Locations
-
-
-
Shanghai, China, 200092
- Recruiting
- Xinhua hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 10 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children aged 4 years, 0 months and 10 years old and 11 months old, who have been diagnosed by a doctor who is at least the attending physician in the pediatric psychiatric department and meet the American Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) ADHD diagnostic criteria, have a total IQ higher than 80, and the subjects are doing this The baseline level of the study has not received any medical treatment before.
Exclusion Criteria:
- Attention deficit disorder caused by organic diseases of the nervous system, extensive developmental disorders, mental retardation, childhood schizophrenia, mood disorders, epilepsy, and other organic diseases or other primary mental disorders; exclude parents or guardians from suffering Severe mental illness, such as schizophrenia, mood disorders (onset period), etc., and a degree below junior high school.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ADHD group
Child diagnosed with ADHD
|
Intervention programs include Child Training and Training in real scenes
|
|
No Intervention: control group
Children without any diagnosis
|
|
|
Experimental: ADHD+ODD/CD group
Child diagnosed with ADHD+ODD/CD
|
Intervention programs include Child Training and Training in real scenes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Apathy and ruthlessness(CU traits) of 60 children with ADHD
Time Frame: Collected when the case is enrolled
|
The CU traits of children with ADHD assessed by A CU questionnaire tests.
|
Collected when the case is enrolled
|
|
Apathy and ruthlessness(CU traits) of 60 children with ADHD+ODD/CD
Time Frame: Collected when the case is enrolled
|
The CU traits of children with ADHD assessed by A CU questionnaire tests.
|
Collected when the case is enrolled
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The executive function in real life of 120 children with ADHD
Time Frame: through the intervention completion, an average of 8 weeks
|
The executive function in real life of 120 children with ADHD assessed by BRIEF
|
through the intervention completion, an average of 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jingyi Wu, Master, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2021
Primary Completion (Anticipated)
December 1, 2021
Study Completion (Anticipated)
March 31, 2022
Study Registration Dates
First Submitted
July 23, 2021
First Submitted That Met QC Criteria
October 9, 2021
First Posted (Actual)
October 12, 2021
Study Record Updates
Last Update Posted (Actual)
October 12, 2021
Last Update Submitted That Met QC Criteria
October 9, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- XH-21-007
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lack of; Attention, With Hyperactivity (ADHD)
-
EMOTIVCompletedADHD | ADHD - Combined Type | ADHD - Attention Deficit Disorder With HyperactivitySouth Korea
-
Qbtech ABEnrolling by invitationAttention Deficit Hyperactivity Disorder (ADHD) | Healthy Volunteer | No History of ADHDUnited States
-
Wuhan Sports UniversityTerminatedADHD | ADHD - Combined Type | ADHD - Inattentive Type | ADHD - Attention Deficit Disorder With Hyperactivity | ADHD Specifically With Executive Function ImpairmentChina
-
Seattle Children's HospitalRecruitingADHD | ADHD - Attention Deficit Disorder With HyperactivityUnited States
-
I-Ching ChouBened Biomedical Co., Ltd.Enrolling by invitationADD/ADHD | ADHD - Attention Deficit Disorder With HyperactivityTaiwan
-
Duke UniversityRecruitingADHD | ADHD - Attention Deficit Disorder With HyperactivityUnited States
-
Çağlar Charles Daniel JaicksCompletedADHD | Attention Deficit Hyperactivity Disorder (ADHD)Turkey (Türkiye)
-
Duke UniversityNational Institute of Mental Health (NIMH)RecruitingADHD | ADHD - Attention Deficit Disorder With HyperactivityUnited States
-
Uskudar UniversityCompletedSpecific Learning Disability | Lack of; Attention, With Hyperactivity (ADHD)Turkey
-
Istituto Giannina GasliniUniversity of Genova; IRCCS Fondazione Stella MarisRecruitingADHD - Attention Deficit Disorder With HyperactivityItaly
Clinical Trials on Emotion Control Treatment Program
-
Linkoeping UniversityCompletedEating DisordersSweden
-
Northwell HealthWithdrawn
-
Northwestern UniversityUniversity of California, San FranciscoCompleted
-
Tel Aviv UniversityRecruiting
-
Xinhua Hospital, Shanghai Jiao Tong University...Recruiting
-
McMaster UniversityNot yet recruiting
-
Hacettepe UniversityNot yet recruitingCompassion Fatigue | Emotion Regulation | Emotion Regulation Abilities | Experiential AvoidanceTurkey
-
Universitat Jaume IConsorcio Hospitalario Provincial de CastellónCompletedDepression | AnxietySpain